Adopting intensive lifestyle changes can slow or stop progression of early-stage Alzheimer’s disease, according to a new ...

As her memory faded from Alzheimer’s disease in her late 50s, Tammy Maida began to lose track of her life. Car keys, ...

Swiss pharmaceutical giant Roche is set to explore the potential of its experimental drug, Trontinemab, in delaying or ...

Lecanemab received traditional approval in the U.S. in July 2023 for the treatment of early Alzheimer's disease (AD). This retrospective study was conducted to investigate the actual state of ...

What if your doctor could, when you turn 65, order a test that predicts whether you are going to develop Alzheimer’s dementia in your 70s or 80s? And what if – in case the test comes back ...

Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025 </str ...

Dementia, a condition impacting memory and cognitive functions, poses a significant global health challenge. Research ...

New research results reported at the Alzheimer's Association International Conference® 2025 (AAIC®) advanced scientific understanding of ...

Dr Emmanuel Iwuozo, a consultant neurologist at the Benue State University Teaching Hospital in Makurdi, Benue State, and ...

Alpha Cognition's ZUNVEYL targets Alzheimer's with improved tolerability over existing galantamine therapies. Read why I rate ...

Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust clearance of amyloid plaques, with 91% ...

Brain scans capture memory formation in babies, raising new questions about why people forget their earliest years ...